Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$451K Sell
940
-12,098
-93% -$6.19M 0.04% 356
2025
Q4
$7.32M Buy
13,038
+11,804
+957% +$6.7M 0.72% 24
2025
Q3
$634K Buy
1,234
+112
+10% +$48.9K 0.06% 290
2025
Q2
$352K Sell
1,122
-441
-28% -$132K 0.04% 419
2025
Q1
$476K Sell
1,563
-1,527
-49% -$514K 0.05% 319
2024
Q4
$1.03M Buy
3,090
+28
+0.9% +$9.5K 0.12% 183
2024
Q3
$1.02M Sell
3,062
-309
-9% -$117K 0.12% 193
2024
Q2
$1.39M Buy
3,371
+701
+26% +$278K 0.28% 78
2024
Q1
$1.08M Sell
2,670
-2,344
-47% -$824K 0.22% 106
2023
Q4
$1.54M Buy
5,014
+3,385
+208% +$914K 0.26% 38
2023
Q3
$394K Buy
+1,629
New +$417K 0.13% 151

Other funds holding MEDP

Norden Group's MEDP Position: Q1 2026 in Review

Norden Group reduced its Medpace (MEDP) stake by 93% in Q1 2026, selling an estimated $6.19M and leaving 940 shares worth $451K. The position accounts for 0.04% of the portfolio, ranked #356.

Norden Group first reported a position in MEDP in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.32M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Norden Group held 940 shares of Medpace worth $451K as of Q1 2026.
  • Norden Group sold 12,098 Medpace shares in Q1 2026, an estimated $6.19M.
  • Medpace made up 0.04% of Norden Group's portfolio in Q1 2026, its #356 holding.
  • Norden Group first reported a position in Medpace in Q3 2023 and has held it in 11 quarters since.
  • Norden Group's Medpace position peaked at $7.32M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.